Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia

Published:2015-04-24 Issue:2 Volume:96 Page:160-169
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Toft Nina¹,Birgens Henrik¹,Abrahamsson Jonas²,Griškevičius Laimonas³,Hallböök Helene⁴,Heyman Mats⁵,Klausen Tobias Wirenfeldt¹,Jónsson Ólafur Gísli⁶,Palk Katrin⁷,Pruunsild Kaie⁸,Quist-Paulsen Petter⁹,Vaitkeviciene Goda¹⁰,Vettenranta Kim¹¹,Asberg Ann¹²,Helt Louise Rold¹³,Frandsen Thomas¹³,Schmiegelow Kjeld¹³¹⁴

Affiliation:

1. Department of Hematology; Herlev University Hospital; University of Copenhagen; Herlev Denmark

2. Department of Clinical Sciences; Queen Silvia's Children's Hospital; Gothenburg Sweden

3. Hematology, Oncology and Transfusion Medicine Center Vilnius University Hospital Santariskiu Klinikos; Vilnius Lithuania

4. Department of Hematology; Uppsala University Hospital; Uppsala Sweden

5. Childhood Cancer Research Unit; Karolinska Institute; Astrid Lindgren's Children's Hospital; Karolinska University Hospital; Stockholm Sweden

6. Children's Hospital; Landspitali University Hospital; Reykjavík Iceland

7. Department of Hematology; North Estonia Medical Centre; Tallinn Estonia

8. Kaie Pruunsild; Tallinn Children's Hospital; Tallinn Estonia

9. Department of Hematology; St. Olav's Hospital; Trondheim University Hospital; Trondheim Norway

10. Centre for Pediatric Oncology and Hematology; Children's Hospital; Affiliate of Vilnius University Hospital Santariskiu Klinikos; Vilnius Lithuania

11. Division of Hematology-Oncology and Stem Cell Transplantation; Hospital for Children and Adolescents; Helsinki University Central Hospital; Helsinki Finland

12. Department of Pediatrics; St. Olav's Hospital; Trondheim University Hospital; Trondheim Norway

13. Department of Pediatrics and Adolescent Medicine; Rigshospitalet; Copenhagen Denmark

14. Institute of Gynecology; Obstetrics and Pediatrics; Faculty of Medicine. University of Copenhagen; Copenhagen Denmark

Funder

Kraeftens Bekaempelse

Danish Childhood Cancer Foundation

Herlev University Hospital Research Council

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12562/fullpdf

Reference31 articles.

1. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials;Boissel;J Clin Oncol,2003

2. The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties;Chessells;Leukemia,1998

3. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands;Bont;Leukemia,2004

4. Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol;Hallbook;Cancer,2006

5. Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials;Ramanujachar;Pediatr Blood Cancer,2007

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intestinal mucositis, systemic inflammation and bloodstream infections following high‐dose methotrexate treatment in childhood acute lymphoblastic leukaemia: Comparison between the NOPHO ALL 2008 protocol and the ALLTogether1 protocol;International Journal of Cancer;2024-08-16

2. Parents' perception of treatment‐related toxicity in children treated according to the NOPHO ALL2008 protocol for acute lymphoblastic leukemia;HemaSphere;2024-07

3. Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection;Current Hematologic Malignancy Reports;2024-06-13

4. How I treat newly diagnosed acute lymphoblastic leukemia;Clinical Hematology International;2024-05-09

5. Osteonecrosis in children and young adults treated for acute lymphoblastic leukemia: A scoping review;EJC Paediatric Oncology;2023-12